Piezo1 ion channel-mediated fluid shear stress inhibits the apoptosis of MLO-Y4 osteocytes(PDF)
《中国医学物理学杂志》[ISSN:1005-202X/CN:44-1351/R]
- Issue:
- 2022年第10期
- Page:
- 1287-1292
- Research Field:
- 医学生物物理
- Publishing date:
Info
- Title:
- Piezo1 ion channel-mediated fluid shear stress inhibits the apoptosis of MLO-Y4 osteocytes
- Author(s):
- LIU Zhongcheng; HE Liangzhi; YI Qiong; LIU Xuening; ZHANG Kun; WANG Lifu; GENG Bin; XIA Yayi; JIANG Jin
- Gansu Provincial Key Laboratory of Orthopaedics/Department of Orthopaedics, Lanzhou University Second Hospital, Lanzhou 730000, China
- Keywords:
- Keywords: fluid shear stress Piezo1 osteocytes apoptosis
- PACS:
- R318;R329.2
- DOI:
- DOI:10.3969/j.issn.1005-202X.2022.10.018
- Abstract:
- Abstract: Objective To investigate the regulation of mechanosensitive ion channel Piezo1 on osteocytes. Methods Immunofluorescence staining was used to investigate the best condition for Piezo1 channel-mediated FSS loaded by the self-developed fluid shear stress (FSS) loading device on MLO-Y4 osteocytes. Piezo1 was intervened with FSS, Piezo1 activator Yoda1, or Piezo1 blocker GsMTx4. The expression levels of apoptosis-related proteins (Cleaved Caspase-3, Bcl-2, and Bax) were analyzed using Western Blot analysis, and the apoptosis rates of MLO-Y4 osteocytes was detected by Hoechst-33258 and flow cytometry. Results The result of immunofluorescence staining indicated that in MLO-Y4 osteocytes exposed to FSS, the expression of Piezo1 had a unimodal tendency of increasing firstly and then decreasing, and that the optimal stimulation condition was 9 dyne/cm2 loading for 30 minutes. Yoda1 inhibited the apoptosis of MLO-Y4 osteocytes (P<0.05), and GsMTx4 promoted the apoptosis of MLO-Y4 osteocytes (P<0.05). Piezo1-mediated FSS inhibited the apoptosis of MLO-Y4 osteocytes (P<0.05). Conclusion When loading FSS at 9 dyne/cm2, the FSS mediated by mechanosensitive ion channel Piezo1 can inhibit the apoptosis of MLO-Y4 osteocytes, and FSS can effectively reverse the apoptosis of MLO-Y4 osteocytes promoted with Piezo1 blocker GsMTx4 at 4 μmol/L for 0.5 h.
Last Update: 2022-10-27